Cargando…
Macrophages protect against loss of adipose tissue during cancer cachexia
BACKGROUND: Cancer cachexia represents a central obstacle in medical oncology as it is associated with poor therapy response and reduced overall survival. Systemic inflammation is considered to be a key driver of cancer cachexia; however, clinical studies with anti‐inflammatory drugs failed to show...
Autores principales: | Erdem, Merve, Möckel, Diana, Jumpertz, Sandra, John, Cathleen, Fragoulis, Athanassios, Rudolph, Ines, Wulfmeier, Johanna, Springer, Jochen, Horn, Henrike, Koch, Marco, Lurje, Georg, Lammers, Twan, Olde Damink, Steven, van der Kroft, Gregory, Gremse, Felix, Cramer, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818538/ https://www.ncbi.nlm.nih.gov/pubmed/31318182 http://dx.doi.org/10.1002/jcsm.12450 |
Ejemplares similares
-
Kinetic modelling of quantitative proteome data predicts metabolic reprogramming of liver cancer
por: Berndt, Nikolaus, et al.
Publicado: (2019) -
Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia
por: Deng, Min, et al.
Publicado: (2023) -
Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment
por: Drescher, Cathleen, et al.
Publicado: (2015) -
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC
por: Kroh, Andreas, et al.
Publicado: (2023) -
Activation of the Complement System in Patients with Cancer Cachexia
por: Deng, Min, et al.
Publicado: (2021)